Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Oct 07, 2020 12:13pm
164 Views
Post# 31680291

RE:RE:RE:RE:Wtf

RE:RE:RE:RE:Wtf
Hummmm,,,it should be assumed that this BTD would give DMcC the edged needed to get multiple interested parties at the table and a much greater ability to push 208 over the finish line,,,,,!

However,,,since the desigantion has been given Don hasnt helped this share price find market interest,,,,not sure why not,,,,,,seems other companies who garnered this prestigious designation were well compensated for it by the market in short order,,,,,its sort of a failure to launch here,,,,a year in limbo and really no solid footing these past 12 months,,,,lots of talk of course,,,,but we all know talk is cheap,,,,,and in the market it also reflects in our share price ,,,,,,,,cheap!

<< Previous
Bullboard Posts
Next >>